RadNet, Inc.(RDNT)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
RadNet, Inc. (RDNT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RDNT at 58.6/100 on a 32-signal composite quality model, placing it at rank #998 of 2,960 stocks — the top half of the AI-ranked universe. RDNT scores in the top quartile across earnings quality (97.4). Areas of concern include profitability (30.9) and balance sheet strength (31.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), RadNet, Inc. reports quarterly revenue of $622.7M, net income of $7.5M, an operating margin of 6.3%. Top institutional holders of RDNT by reported 13-F value include BlackRock, RTW INVESTMENTS, PRICE T ROWE ASSOCIATES, based on the most recent SEC filings. RDNT trades on the Nasdaq exchange and files with the SEC under CIK 790526. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RDNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RadNet, Inc. directly from SEC EDGAR.
AI Quality Score
58.6/100
AI Rank
#998
Revenue
$622.7M
Net Income
$7.5M
Operating Margin
6.3%
RDNT key financials by period
RadNet, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$2.0B
$-18.7M
3.0%
FY 2024
10-K
$1.8B
$2.8M
5.7%
FY 2023
10-K
$1.6B
$3.0M
6.1%
FY 2022
10-K
$1.4B
$10.7M
3.2%
FY 2021
10-K
$1.3B
$24.7M
6.3%
FY 2020
10-K
$1.1B
$-14.8M
3.3%
Institutions holding RDNT
Institutional investors reporting a position in RadNet, Inc. on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-08-10 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
RadNet Q2 revenue reached $622.7M (+25.0% YoY), driven by 11.1% same-center imaging growth and strong Digital Health expansion to $32.4M (+56.5% YoY), though Digital Health segment losses widened.
Biggest Revenue Drivers
Imaging Centers$601.8M+23.5% YoY
Same-center revenue +11.1% driven by higher procedural volumes, increased reimbursement from commercial and capitated payors, and favorable shift to advanced imaging (PET/CT for prostate cancer and Alzheimer's studies).
Digital Health$32.4M+56.5% YoY
Clinical AI revenue increased 135.9%; Enterprise Informatics revenue +17.3%; customer base expanded to 2,983 from 463 YoY; procedure volumes supported increased to 17.3M from 5.3M.
Biggest Revenue Drivers
Total revenue: $622.7M+25.0% YoY
Imaging Centers$601.8M+23.5% YoY
Same-center revenue +11.1% driven by higher procedural volumes, increased reimbursement from commercial and capitated payors, and favorable shift to advanced imaging (PET/CT for prostate cancer and Alzheimer's studies).
Clinical AI revenue increased 135.9%; Enterprise Informatics revenue +17.3%; customer base expanded to 2,983 from 463 YoY; procedure volumes supported increased to 17.3M from 5.3M.
Capitation arrangements revenue$30.1M-0.1% YoY
Per-enrollee monthly arrangements with health plans remained stable.
Largest Expense Items
Depreciation and amortization$45.5M+26.4% YoY
Higher depreciable asset base from acquisitions and capital investments during period.
Interest expense$18.2M+5.6% YoY
Adjusted interest expense (excluding derivatives) decreased 0.6% to $17.4M; benefits from 0.25% rate reduction offset by higher average debt balances from $250M incremental term loan.
Margins: Imaging Centers segment profit margin improved to 15.4% ($92.8M) from 15.0% ($73.1M) YoY despite 11.9% same-center operating leverage, driven by labor efficiency and workflow optimization including early DeepHealth deployment. Digital Health segment operating loss widened to $14.6M from $7.1M, reflecting integration costs of Gleamer, iCAD, See-Mode and CIMAR acquisitions and continued investments in AI platform scaling.
Watch Items from the Filing
Digital Health segment operating losses accelerated to $14.6M in Q2 2026 vs. $7.1M in Q2 2025 and $32.3M for six months ended June 30, 2026 vs. $13.2M YoY; segment expected to remain unprofitable near-term despite $105.5M ARR (+97% YoY).
Goodwill increased $218.6M to $1,122.5M (6M period) primarily from Gleamer ($171.1M goodwill recorded); company noted no impairment indicators as of June 30, 2026 but digital acquisitions carry execution and integration risk.
Term loan debt increased to $1,323.7M from $1,084.9M at year-end 2025 due to $250M incremental borrowing in June 2026; quarterly principal payments rose to $3.1M; maturity April 18, 2031.
On August 1, 2026 (subsequent event), RadNet restructured Maryland imaging joint ventures to form Maryland Imaging Partners, LLC retaining 80% ownership and contributing six wholly-owned Maryland centers; now operates 19 Maryland imaging centers.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
